Kadimastem Shareholders Approve Merger with NLS Pharmaceutics
The merger brings NLS and Kadimastem one step closer to creating a combined Nasdaq-traded biotechnology company with a robust portfolio of advanced therapies for neurodegenerative diseases and diabetes.
Merger | 01/02/2025 | By Abha
Vector Laboratories and Absolute Biotech Announce Merger to Enhance Life Sciences Offerings
This strategic move aims to solidify Vector Laboratories' position as a comprehensive supplier of custom-engineered and catalog antibodies, sophisticated bioconjugation linkers, and expertise in bioconjugation.
Merger | 20/05/2024 | By Abha | 263
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy